Justera Health (SCRSF) has a profit margin of -290.97%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2024
Trailing 12 months ending Dec 2024
The latest profit margin for SCRSF is -290.97% as of December 2024. That compares with -155.71% in the prior-year period — down 86.9% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside Justera Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, SCRSF's profit margin moved from -155.71% to -290.97% — a 86.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Justera Health's valuation or profitability profile.
Against its sector companies, SCRSF currently prints -290.97% for profit margin, while the sector average sits near 13.4%. That is roughly 2270.9% below the sector mean. Large gaps often invite a closer look at Justera Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Justera Health converts resources into returns. At -290.97%, SCRSF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -155.71% in the prior-year period — down 86.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SCRSF's profit margin (-290.97%), review year-over-year change from -155.71%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.